104 related articles for article (PubMed ID: 22274317)
1. Family history and women with ovarian cancer: is it asked and does it matter?: An observational study.
Lanceley A; Eagle Z; Ogden G; Gessler S; Razvi K; Ledermann JA; Side L
Int J Gynecol Cancer; 2012 Feb; 22(2):254-9. PubMed ID: 22274317
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Impact of family history risk assessment on surgical decisions and imaging surveillance at breast cancer diagnosis.
Jones S; Turton P; Achuthan R
Ann R Coll Surg Engl; 2020 Oct; 102(8):590-593. PubMed ID: 32436722
[TBL] [Abstract][Full Text] [Related]
4. Is family history related to preventive health behaviors and medical management in breast cancer patients?
Madlensky L; Flatt SW; Bardwell WA; Rock CL; Pierce JP;
Breast Cancer Res Treat; 2005 Mar; 90(1):47-54. PubMed ID: 15770526
[TBL] [Abstract][Full Text] [Related]
5. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
[TBL] [Abstract][Full Text] [Related]
7. Family history of cancer in Brazil: is it being used?
Viana DV; Góes JR; Coy CS; de Lourdes Setsuko Ayrizono M; Lima CS; Lopes-Cendes I
Fam Cancer; 2008; 7(3):229-32. PubMed ID: 18193339
[TBL] [Abstract][Full Text] [Related]
8. Recording of family history is associated with colorectal cancer stage.
Kessels K; de Groot NL; Fidder HH; Timmer R; Stolk MF; Offerhaus GJ; Siersema PD;
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):482-7. PubMed ID: 23470269
[TBL] [Abstract][Full Text] [Related]
9. Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic.
Kishan AU; Gomez CL; Dawson NA; Dvorak R; Foster NM; Hoyt A; Hurvitz SA; Kusske A; Silver EL; Tseng C; McCloskey SA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):634-641. PubMed ID: 27619940
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R
Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991
[TBL] [Abstract][Full Text] [Related]
11. Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
Brannon Traxler L; Martin ML; Kerber AS; Bellcross CA; Crane BE; Green V; Matthews R; Paris NM; Gabram SG
Ann Surg Oncol; 2014 Oct; 21(10):3342-7. PubMed ID: 25047474
[TBL] [Abstract][Full Text] [Related]
12. Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
Crawford B; Adams SB; Sittler T; van den Akker J; Chan S; Leitner O; Ryan L; Gil E; van 't Veer L
Breast Cancer Res Treat; 2017 Jun; 163(2):383-390. PubMed ID: 28281021
[TBL] [Abstract][Full Text] [Related]
13. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population.
Dominguez FJ; Jones JL; Zabicki K; Smith BL; Gadd MA; Specht M; Kopans DB; Moore RH; Michaelson JS; Hughes KS
Cancer; 2005 Nov; 104(9):1849-53. PubMed ID: 16136597
[TBL] [Abstract][Full Text] [Related]
15. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
Metcalfe K; Lubinski J; Lynch HT; Ghadirian P; Foulkes WD; Kim-Sing C; Neuhausen S; Tung N; Rosen B; Gronwald J; Ainsworth P; Sweet K; Eisen A; Sun P; Narod SA;
J Natl Cancer Inst; 2010 Dec; 102(24):1874-8. PubMed ID: 21098759
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
17. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
18. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
Minion LE; Dolinsky JS; Chase DM; Dunlop CL; Chao EC; Monk BJ
Gynecol Oncol; 2015 Apr; 137(1):86-92. PubMed ID: 25622547
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of probability of BRCA1 and BRCA2 mutations carriage in women with compromised family history of breast and/or ovarian cancer.
Rybchenko LA; Bychkova AM; Skyban GV; Klymenko SV
Probl Radiac Med Radiobiol; 2013; (18):253-60. PubMed ID: 25191729
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]